Veradermics, Incorporated (MANE)

PHARMACEUTICAL PREPARATIONS

Headquarters
United States
Employees
21
Market Cap
$4.4B

About Veradermics, Incorporated

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

SentiSense also tracks daily options readings for Veradermics, Incorporated: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.

Veradermics, Incorporated stock analysis, sentiment tracking, and market intelligence on SentiSense.